Assyro AI

Orange Book product · Brand (NDA)

JATENZO

TESTOSTERONE UNDECANOATE

Brand (NDA)NDA 206089RX TOLMAR

At a glance

Mar 27, 2019

Approved

Brand (NDA)

Application

Not listed

TE code

11

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 27, 2019

    7 yr 4 mo ago

  2. Patent 11179402 expires

    Listed drug substance patent expiration.

    Apr 14, 2026

    2 mo ago

  3. Today

  4. Patent 11331325 expires

    Listed method-of-use patent (U-2506) expiration.

    Jan 06, 2027

    in 7 mo

  5. Patent 8241664 expires

    Listed drug product patent expiration.

    Mar 29, 2029

    in 2 yr 10 mo

  6. Patent 10543219 expires

    Listed method-of-use patent (U-2506) expiration.

    Apr 12, 2030

    in 3 yr 10 mo

  7. Patent 10617696 expires

    Listed drug substance patent expiration.

    Apr 12, 2030

    in 3 yr 10 mo

  8. Patent 11179403 expires

    Listed method-of-use patent (U-2506) expiration.

    Apr 12, 2030

    in 3 yr 10 mo

  9. Patent 11426416 expires

    Listed method-of-use patent (U-3420) expiration.

    Apr 12, 2030

    in 3 yr 10 mo

  10. Patent 8778916 expires

    Listed drug product patent expiration.

    Apr 12, 2030

    in 3 yr 10 mo

  11. Patent 8492369 expires

    Listed drug product patent expiration.

    Dec 20, 2030

    in 4 yr 7 mo

  12. Patent 11564933 expires

    Listed method-of-use patent (U-1103) expiration.

    Apr 12, 2039

    in 13 yr

  13. Patent 12605391 expires

    Listed method-of-use patent (U-1103) expiration.

    Apr 12, 2039

    in 13 yr

Pharmaceutical detail

Active ingredient

TESTOSTERONE UNDECANOATE

Strength

158MG

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

NDA 206089

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (11)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11179402Apr 14, 20262 mo ago
SubstanceProduct
11331325Jan 06, 2027in 7 mo
U-2506
8241664Mar 29, 2029in 2 yr 10 mo
ProductU-2506
10543219Apr 12, 2030in 3 yr 10 mo
U-2506
10617696Apr 12, 2030in 3 yr 10 mo
SubstanceProduct
11179403Apr 12, 2030in 3 yr 10 mo
U-2506
11426416Apr 12, 2030in 3 yr 10 mo
U-3420
8778916Apr 12, 2030in 3 yr 10 mo
Product
8492369Dec 20, 2030in 4 yr 7 mo
ProductU-2506
11564933Apr 12, 2039in 13 yr
U-1103
12605391Apr 12, 2039in 13 yr
U-1103
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.